Back
Corporate News
Marksans Pharma to review quarterly results at a Mumbai board meeting on August 12
31-Jul-2026, 01:34
Marksans Pharma Ltd. will hold a board meeting on Wednesday, August 12, 2026, in Mumbai to consider and approve the unaudited financial results for both standalone and consolidated entities for the quarter ended June 30, 2026, according to a regulatory filing. The company has closed the trading window for its designated persons, including directors, from July 1, 2026, until August 14, 2026, in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
Marksans Pharma Ltd. will hold a board meeting on Wednesday, August 12, 2026, in Mumbai to consider and approve the unaudited financial results for both standalone and consolidated entities for the quarter ended June 30, 2026, according to a regulatory filing. The company has closed the trading window for its designated persons, including directors, from July 1, 2026, until August 14, 2026, in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.